John Dwyer

Serial entrepreneur bringing disruptive innovation to Alzheimer’s research

John Dwyer, Jr. is a prominent figure in the healthcare industry, particularly in the areas of Alzheimer's disease and other neurodegenerative conditions. Here are some key points about his background and achievements:

Current Role

John Dwyer is the President and co-founder of the Global Alzheimer's Platform Foundation (GAP), a nonprofit organization dedicated to making the clinical trial process for Alzheimer’s and Parkinson’s therapies more efficient, thereby speeding up the delivery of treatments to patients.1 2 5

Educational Background

He is a graduate of Marquette University and Cornell Law School.1 2 5

Career

Early Career: Dwyer began his career as an attorney with the Washington, D.C.-based law firm Arent, Fox LLP, focusing on transactions in regulated industries.1 2 5
Healthcare Entrepreneurship: He became a CEO at the age of 30 and has since held "C" level positions in six emerging growth companies in the healthcare industry. Notable ventures include:
- Co-founder and Chairman of Telcare, Inc., which developed the first wirelessly enabled blood glucose meter for diabetes management.1 2 5
- Co-founder and Chairman of CodeRyte, Inc., a company that used natural language processing for medical billing, later acquired by 3M.1 2 5
- CEO of e-Medex, Inc., which merged with Active Health Management and was later acquired by Aetna.1 2 5

Advocacy and Public Service

UsAgainstAlzheimer’s: Dwyer co-founded this patient advocacy group to change the way Alzheimer’s is addressed in the United States.1 2 5
Alzheimer’s Action PAC: He also co-founded the first political action committee focused on a specific disease, the Alzheimer’s Action PAC.1 2 5

Current Focus

At GAP, Dwyer is focused on:

Reducing the time and cost of clinical trials for Alzheimer’s and Parkinson’s diseases.
Promoting diversity in clinical research and ensuring that no one is left behind.
Collaborating with international organizations and global partners to innovate clinical trial design and recruitment.3 4

Additional Roles and Contributions

Dwyer serves on the Boards of Directors of several private and not-for-profit organizations.
He is a frequent speaker on financing, regulatory issues, and health information topics relevant to emerging health technology companies.1 2

Overall, John Dwyer is a serial healthcare entrepreneur and a dedicated advocate for accelerating the development and delivery of treatments for Alzheimer’s and other neurodegenerative diseases.